PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Abbott Laboratories | ABT | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 83.58 | 0.00 | 0.00 | 0.00 | 83.58 | 05:28:04 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.00 | USD |
Abbott Laboratories Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 147.72B | 1.77B | $ 2.37B | 1.33 | 52.30 | 1.75B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 15.42M | $ 1.12 | 1.34% | 10/11/19 | - | - |
Abbott Laboratories News
| Date | Time | Source | News Article |
|---|---|---|---|
| 9/17/2019 | 09:00 | PR Newswire (US) | Abbott Announces European Approval of Two Life-saving Heart.. |
| 9/16/2019 | 11:45 | PR Newswire (US) | Abbott Named the Industry Leader in Sustainability for the.. |
| 9/16/2019 | 11:33 | PR Newswire (US) | Abbott Named the Industry Leader in Sustainability for the.. |
| 9/16/2019 | 08:00 | PR Newswire (US) | Abbott and Sanofi Partner to Integrate Glucose Sensing and.. |
| 9/13/2019 | 08:00 | PR Newswire (Canada) | Abbott's Revolutionary FreeStyle® Libre System Now.. |
| 9/12/2019 | 17:03 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) |
| 9/12/2019 | 12:56 | PR Newswire (US) | Abbott Declares 383rd Consecutive Quarterly Dividend |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 82.45 | 85.99 | 82.12 | 84.2644 | 3M | 1.13 | 1.37% |
| 1 Month | 85.22 | 86.58 | 81.02 | 84.1866 | 4M | -1.64 | -1.92% |
| 3 Months | 84.05 | 88.98 | 81.02 | 85.1943 | 5M | -0.47 | -0.56% |
| 6 Months | 80 | 88.98 | 72.36 | 81.3470 | 5M | 3.58 | 4.48% |
| 1 Year | 67.76 | 88.98 | 65.44 | 75.8989 | 6M | 15.82 | 23.35% |
| 3 Years | 42.036 | 88.98 | 37.38 | 58.8170 | 6M | 41.544 | 98.83% |
| 5 Years | 43.49 | 88.98 | 36 | 52.1734 | 6M | 40.09 | 92.18% |
Abbott Laboratories Description
| Abbott manufactures and markets medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and molecular and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. |
